Miscellaneous
Prostate-specific membrane antigen (PSMA) is overexpressed in more than 80% of prostate cancer tumors, making it a promising diagnostic and... The post ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer appeared first on VJOncology.